These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2823512)

  • 1. Effects of caffeine on monoaminergic systems in mouse brain.
    Reith ME; Sershen H; Lajtha A
    Acta Biochim Biophys Hung; 1987; 22(2-3):149-63. PubMed ID: 2823512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A portion of [3H]cocaine binding in brain is associated with serotonergic neurons.
    Reith ME; Sershen H; Allen DL; Lajtha A
    Mol Pharmacol; 1983 May; 23(3):600-6. PubMed ID: 6865907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of substituted phenylethylamines on brain serotonergic mechanisms.
    Chung Hwang E; Van Woert MH
    J Pharmacol Exp Ther; 1980 May; 213(2):254-60. PubMed ID: 6965983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of the inhibiting effect of atypical antidepressants and psychostimulants on the synaptosomal uptake of monoamines].
    Gankina EM; Maĭsov NI
    Biull Eksp Biol Med; 1983 Aug; 96(8):52-4. PubMed ID: 6224517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of some quinolizidine derivatives on the release of serotonin, noradrenaline, dopamine and acetylcholine from rat brain synaptosomes.
    Sparatore A; Marchi M; Maura G; Raiteri M
    Farmaco; 1989 Dec; 44(12):1205-16. PubMed ID: 2634407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine.
    Ritz MC; Kuhar MJ
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1010-7. PubMed ID: 2703961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of supidimide on brain neurotransmitter systems of rats and mice.
    Hennies HH; Günzler WA; Flohé L
    Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes.
    Tuomisto J; Tuomisto L
    Med Biol; 1980 Feb; 58(1):33-7. PubMed ID: 7382578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release.
    Raiteri M; Maura G; Versace P
    J Pharmacol Exp Ther; 1983 Mar; 224(3):679-84. PubMed ID: 6298406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic cocaine administration on [3H]dopamine uptake in the nucleus accumbens, striatum and frontal cortex of rats.
    Masserano JM; Venable D; Wyatt RJ
    J Pharmacol Exp Ther; 1994 Jul; 270(1):133-41. PubMed ID: 8035309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
    Henderson MG; McMillen BA
    Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity of hydroxylated tryptamines: structure-activity relationships. 2. In vitro studies on monoamine uptake inhibition and uptake impairment.
    Björklund A; Horn AS; Baumgarten HG; Nobin A; Schlossberger HG
    Acta Physiol Scand Suppl; 1975; 429():29-60. PubMed ID: 1064286
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic profile of fezolamine fumarate: a nontricyclic antidepressant in animal models.
    Baizman ER; Ezrin AM; Ferrari RA; Luttinger D
    J Pharmacol Exp Ther; 1987 Oct; 243(1):40-54. PubMed ID: 3668867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.